Gilead Sciences (GILD) Total Current Liabilities (2016 - 2025)
Gilead Sciences' Total Current Liabilities history spans 17 years, with the latest figure at $11.8 billion for Q4 2025.
- For Q4 2025, Total Current Liabilities fell 1.59% year-over-year to $11.8 billion; the TTM value through Dec 2025 reached $11.8 billion, down 1.59%, while the annual FY2025 figure was $11.8 billion, 1.59% down from the prior year.
- Total Current Liabilities reached $11.8 billion in Q4 2025 per GILD's latest filing, down from $12.3 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $14.0 billion in Q2 2023 to a low of $8.6 billion in Q1 2022.
- Average Total Current Liabilities over 5 years is $11.2 billion, with a median of $11.3 billion recorded in 2022.
- Peak YoY movement for Total Current Liabilities: surged 51.45% in 2023, then decreased 22.79% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $11.6 billion in 2021, then fell by 3.21% to $11.2 billion in 2022, then grew by 0.38% to $11.3 billion in 2023, then grew by 6.42% to $12.0 billion in 2024, then decreased by 1.59% to $11.8 billion in 2025.
- Per Business Quant, the three most recent readings for GILD's Total Current Liabilities are $11.8 billion (Q4 2025), $12.3 billion (Q3 2025), and $11.2 billion (Q2 2025).